Massimo Gadina
Company: NIAMS/NIH
Job title: Director & Chief of Translational Immunology Section, Science & Technology
Seminars:
An Overview of JAKi in Rheumotology 9:50 am
Historical overview of how JAK inhibitors were developed. Review of first-generation pan-JAK inhibitors and their current clinical application JAK-selective, second-generation JAK inhibitors: what is there already and what is arriving. The effect of JAK inhibitors on circulating immune cellRead more
day: Day One
Chair’s closing remarks 6:00 pm
day: Day One
Speaker Q&A panel 10:25 am
day: Day One
Chair’s Opening Remarks 8:50 am
day: Day One